This slide show features images of melanoma, basal cell carcinoma, squamous cell carcinoma, as well as images of metastatic disease.
Atezolizumab Combo Results in Intracranial Activity in BRAFV600+ Melanoma
September 7th 2023Second-line end points of the TRICOTEL trial assessing atezolizumab plus vemurafenib and cobimetinib in melanoma with central nervous system metastases appear consistent with primary efficacy end points.
2 Clarke Drive
Cranbury, NJ 08512